In October, Cold Spring Harbor Laboratory (CSHL) broke ground on its new Center for Therapeutics Research (CTR) facility in New York, US.
To be built with a $75m investment, the laboratory will support CSHL in research activities for developing novel therapeutics for genetic diseases.
The new research facility will generate 30 new scientific jobs upon completion in 2018. The project will generate 99 full-time positions in construction and 58 full-time-equivalent indirect jobs.
The CTR project will renovate the existing Demerec Laboratory, which was built in 1953. This laboratory is already home to four of the eight CSHL Nobel Prize winners.
Spread over a 26,000ft² area, the building will be equipped with state-of-the-art facilities and equipment.
The New York State is providing a $25m construction and equipment fund for the project, which will be used to modernise the Demerec Laboratory and house the CTR.
The funding is being provided under a state initiative, which aims to create a research corridor on Long Island.
The National Institute of Health is providing the remaining $50m needed to develop the project. This funding will cover recruitment, lab start-up costs, and CTR operations.
The CTR will establish partnerships with academic institutions such as Stony Brook University, the Brookhaven National Laboratory, and Northwell Health to carry out both lab-based and clinical research.
It will enable newly developed compounds to be refined by world-leading chemists to develop next-generation therapies. This research will form a basis for collaboration with private foundations and pharmaceutical companies, while advancing the development of new drugs.
In addition, the centre will support ongoing research activities aimed to develop therapeutics for breast cancer, leukaemia, autism, obesity, diabetes, and lung cancer. The primary goal of such research activities will include the development of advanced drug compounds targeting underlying biological pathways.
Development of the new facility will further, drive the local economy through the creation of additional jobs, spin-offs and new investment.
Cold Spring Harbor Laboratory is a private non-profit organisation established in 1890. The research laboratory focuses on a range of programmes in the areas cancer, neuroscience, plant biology, and quantitative biology.
The institute has more than 1,100 employees including scientists and technicians. It has an education arm, which conducts programmes for high school students and teachers, as well as includes a publishing house and a graduate school.
Apart from the new CTR, the institute also operates the CSHL Cancer Center, which is a basic research facility conducting research on a broad range of cancers. Other facilities include Genome Research Center, Uplands Farm Field Research Center, the Banbury Center, and the Dolan DNA Learning Center.
Thermo Fisher Scientific (Thermo Fisher) will establish a new pharmaceutical services facility for integrated biologics and sterile drug development and…
Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts, US, in September 2020. The…
Merck announced the expansion of its high-potent active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) production capabilities and capacity at…
Contract development and manufacturing organisation (CDMO) Sai Life Sciences inaugurated its new research and technology (R&T) centre in Hyderabad, India…